Tumors of the biliary tract

Michael House, Keith D. Lillemoe

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Most tumors of the biliary tract are malignant and cause symptoms or signs of obstructive jaundice, liver dysfunction, or abdominal pain associated with weight loss. Cancers of the biliary tract are grouped into four major categories: gallbladder cancer, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, and distal cholangiocarcinoma. Major predisposing risk factors for the development of bile duct cancer (cholangiocarcinoma) include chronic inflammatory or infectious conditions and exposure to a carcinogen. Clinical assessment and cross-sectional radiographic imaging with computed tomography and magnetic resonance are mainstay diagnostic tools for the diagnosis and staging of bile duct tumors. Tissue acquisition for histologic or cytopathologic analysis prior to surgical resection remains challenging despite recent major advances in biliary tract examination and molecular testing.

Original languageEnglish (US)
Title of host publicationHandbook of Liver Disease
PublisherElsevier
Pages499-512
Number of pages14
ISBN (Electronic)9780323478823
ISBN (Print)9780323478748
DOIs
StatePublished - Aug 24 2017

Fingerprint

Cholangiocarcinoma
Biliary Tract
Klatskin Tumor
Biliary Tract Neoplasms
Bile Duct Neoplasms
Gallbladder Neoplasms
Neoplasms
Obstructive Jaundice
Bile Ducts
Causality
Carcinogens
Abdominal Pain
Signs and Symptoms
Liver Diseases
Weight Loss
Magnetic Resonance Spectroscopy
Tomography

Keywords

  • Bile duct cancer
  • Gallbladder cancer
  • Intrahepatic
  • Perihilar, and distal cholangiocarcinoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

House, M., & Lillemoe, K. D. (2017). Tumors of the biliary tract. In Handbook of Liver Disease (pp. 499-512). Elsevier. https://doi.org/10.1016/B978-0-323-47874-8.00036-5

Tumors of the biliary tract. / House, Michael; Lillemoe, Keith D.

Handbook of Liver Disease. Elsevier, 2017. p. 499-512.

Research output: Chapter in Book/Report/Conference proceedingChapter

House, M & Lillemoe, KD 2017, Tumors of the biliary tract. in Handbook of Liver Disease. Elsevier, pp. 499-512. https://doi.org/10.1016/B978-0-323-47874-8.00036-5
House M, Lillemoe KD. Tumors of the biliary tract. In Handbook of Liver Disease. Elsevier. 2017. p. 499-512 https://doi.org/10.1016/B978-0-323-47874-8.00036-5
House, Michael ; Lillemoe, Keith D. / Tumors of the biliary tract. Handbook of Liver Disease. Elsevier, 2017. pp. 499-512
@inbook{a5f22aaadf5f41dc9a9fe693cb4017bd,
title = "Tumors of the biliary tract",
abstract = "Most tumors of the biliary tract are malignant and cause symptoms or signs of obstructive jaundice, liver dysfunction, or abdominal pain associated with weight loss. Cancers of the biliary tract are grouped into four major categories: gallbladder cancer, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, and distal cholangiocarcinoma. Major predisposing risk factors for the development of bile duct cancer (cholangiocarcinoma) include chronic inflammatory or infectious conditions and exposure to a carcinogen. Clinical assessment and cross-sectional radiographic imaging with computed tomography and magnetic resonance are mainstay diagnostic tools for the diagnosis and staging of bile duct tumors. Tissue acquisition for histologic or cytopathologic analysis prior to surgical resection remains challenging despite recent major advances in biliary tract examination and molecular testing.",
keywords = "Bile duct cancer, Gallbladder cancer, Intrahepatic, Perihilar, and distal cholangiocarcinoma",
author = "Michael House and Lillemoe, {Keith D.}",
year = "2017",
month = "8",
day = "24",
doi = "10.1016/B978-0-323-47874-8.00036-5",
language = "English (US)",
isbn = "9780323478748",
pages = "499--512",
booktitle = "Handbook of Liver Disease",
publisher = "Elsevier",

}

TY - CHAP

T1 - Tumors of the biliary tract

AU - House, Michael

AU - Lillemoe, Keith D.

PY - 2017/8/24

Y1 - 2017/8/24

N2 - Most tumors of the biliary tract are malignant and cause symptoms or signs of obstructive jaundice, liver dysfunction, or abdominal pain associated with weight loss. Cancers of the biliary tract are grouped into four major categories: gallbladder cancer, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, and distal cholangiocarcinoma. Major predisposing risk factors for the development of bile duct cancer (cholangiocarcinoma) include chronic inflammatory or infectious conditions and exposure to a carcinogen. Clinical assessment and cross-sectional radiographic imaging with computed tomography and magnetic resonance are mainstay diagnostic tools for the diagnosis and staging of bile duct tumors. Tissue acquisition for histologic or cytopathologic analysis prior to surgical resection remains challenging despite recent major advances in biliary tract examination and molecular testing.

AB - Most tumors of the biliary tract are malignant and cause symptoms or signs of obstructive jaundice, liver dysfunction, or abdominal pain associated with weight loss. Cancers of the biliary tract are grouped into four major categories: gallbladder cancer, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, and distal cholangiocarcinoma. Major predisposing risk factors for the development of bile duct cancer (cholangiocarcinoma) include chronic inflammatory or infectious conditions and exposure to a carcinogen. Clinical assessment and cross-sectional radiographic imaging with computed tomography and magnetic resonance are mainstay diagnostic tools for the diagnosis and staging of bile duct tumors. Tissue acquisition for histologic or cytopathologic analysis prior to surgical resection remains challenging despite recent major advances in biliary tract examination and molecular testing.

KW - Bile duct cancer

KW - Gallbladder cancer

KW - Intrahepatic

KW - Perihilar, and distal cholangiocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=85054216164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054216164&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-47874-8.00036-5

DO - 10.1016/B978-0-323-47874-8.00036-5

M3 - Chapter

SN - 9780323478748

SP - 499

EP - 512

BT - Handbook of Liver Disease

PB - Elsevier

ER -